Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, Chris C. J.; Lyall, Helen; Petrie, John R.; Gould, Gwyn W.; Connell, John M. C.; Sattar, Naveed

doi:10.1210/jcem.86.6.7580

Cited by 640Ovarian function and disordersAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, Chris C. J., Lyall, Helen, Petrie, John R., Gould, Gwyn W., Connell, John M. C., Sattar, Naveed·2001·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.86.6.7580

Open this paper in CoChat — free account

Abstract

Low grade chronic inflammation as reflected by increased C-reactive protein (CRP) concentrations independently predicts those at risk for coronary heart disease (CHD) and type 2 diabetes. Women with polycystic ovarian syndrome (PCOS) are insulin resistant and have increased risk for CHD and type 2 diabetes, but currently there are no data on markers of inflammation in women with PCOS. Seventeen women with PCOS (defined on the basis of elevated testosterone and oligomenorrhea) and 15 healthy women matched as a group for body mass index were recruited. Measurement of CRP concentrations was made using a highly sensitive assay. Insulin resistance was assessed using the hyperinsulinemic euglycemic clamp technique. The women with PCOS had significantly elevated CRP concentrations relative to controls (geometric means, 2.12 and 0.67 mg/L, respectively; P = 0.016). Log CRP correlated with body mass index in both PCOS and controls (r = 0.58; P < 0.05 and r = 0.78; P < 0.01, respectively) and inversely with insulin sensitivity (r = -0.57; P < 0.05 and r = -0.69; P < 0.01). Total testosterone did not correlate with log CRP in either group. On adjustment for body mass index and age, there remained a significant difference in log CRP between PCOS and controls (t = 2.13; P < 0.05). On further adjustment for insulin sensitivity, log CRP was no longer significantly different between groups (t = 1.51; P = 0.14). We conclude that women with PCOS have significantly increased CRP concentrations relative to women with normal menstrual rhythm and normal androgen levels. We propose low grade chronic inflammation as a novel mechanism contributing to increased risk of CHD and type 2 diabetes in these women.

Integrity signals

Registry

Crossref · 10.1210/jcem.86.6.7580

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CRP and PAI-1 are reliable markers of inflammation and sensitive predictors of cardiovascular morbidity.
“CRP and PAI-1 are reliable markers of inflammation and sensitive predictors of cardiovascular morbidity.57”
From The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [57]

Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · see citing works
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · see citing works
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,941 · see citing works
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642 · see citing works
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women<sup>1</sup>
Legro, R. S., Kunselman, A. R., Dodson, W. C., & Dunaif, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5393 · Cited by 1,537 · see citing works
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511 · see citing works
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,069 · see citing works
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., POLSON, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 975 · see citing works
Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844 · see citing works
C-Reactive Protein as a Cardiovascular Risk Factor
Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833 · see citing works
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Odén, A., Janson, P. O., Mattson, L.-A., Crona, N., & Lundberg, P.-A. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90704-m · Cited by 527 · see citing works
Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization
Birdsall, M. A., Farquhar, C. M., & White, H. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00005 · Cited by 327 · see citing works
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
Cibula, D. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.785 · Cited by 265 · see citing works
Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
Dunaif, A. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80057-6 · Cited by 235 · see citing works
Clinical signs of androgen excess as risk factors for coronary artery disease
Wild, R. A., Grubb, B. P., Hartz, A. J., Nort, J. J. V., Bachman, W. J., & Bartholomew, M. J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53699-1 · Cited by 183 · see citing works
Anthropometric Variables and Metabolism in Polycystic Ovarian Disease
Rebuffé-Scrive, M., Cullberg, G., Lundberg, P. A., Lindstedt, G., & Björntorp, P. A. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009245 · Cited by 142 · see citing works
Normal Endothelial Function Despite Insulin Resistance in Healthy Women with the Polycystic Ovary Syndrome1
Mather, K. J., Verma, S., Corenblum, B., & Anderson, T. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6587 · Cited by 113 · see citing works
A solid-phase enzyme immunoassay for C-reactive protein: Clinical value and the effect of rheumatoid factor
Highton, J., & Hessian, P. A. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90149-2 · Cited by 64 · see citing works
Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries
Lakhani, K., Constantinovici, N., Purcell, W. M., Fernando, R., & Hardiman, P. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02764-1 · Cited by 36 · see citing works
Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOM-cohort
Gorgels, W. J. M. J., Graaf, Y. V. D., Blankenstein, M. A., Collette, H. J. A., Erkelens, D. W., & Banga, J. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00367-8 · Cited by 35 · see citing works
The long term health consequences of polycystic ovary syndrome
Kelly, C. J., Connell, J., Cameron, I. T., Gould, G. W., & Lyall, H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11644.x · Cited by 29 · see citing works
Abdominal obesity: The critical correlate of elevated plasma C-reactive protein levels associated with the features of the insulin resistance syndrome in men
Després, J., Pascot, A., Bergeron, J., Lemieux, I., Dumont, M., Alméras, N., Nadeau, A., & Prud’homme, D. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)80443-8 · Cited by 6 · see citing works

Flagged first, then by citations

Sorted by citations

Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066 · see citing works
Polycystic ovary syndrome
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · see citing works
Chronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · see citing works
Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways
Ramsay, J. E., Ferrell, W. R., Crawford, L., Wallace, A. M., Greer, I. A., & Sattar, N. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020311 · Cited by 659 · see citing works
Diabetes mellitus and periodontal disease
Mealey, B. L., & Ocampo, G. L. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00193.x · Cited by 565 · see citing works
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 522 · see citing works
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · see citing works
Reactive Oxygen Species-Induced Oxidative Stress in the Development of Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1696 · Cited by 459 · see citing works
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 421 · see citing works
Macrophage contributions to ovarian function
Wu, R. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh011 · Cited by 387 · see citing works
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. R. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372 · see citing works
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
Maas, A. H. E. M., Rosano, G. M. C., Cífková, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E. T. M., Lambrinoudaki, I. V., Maclaran, K., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 361 · see citing works
Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease
Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332 · see citing works
Is PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327 · see citing works
Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome
Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330 · see citing works
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K. B., Nestler, J. E., Sattar, N. A., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 323 · see citing works
The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey
Ford, E. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00134-5 · Cited by 315 · see citing works
High uric acid directly inhibits insulin signalling and induces insulin resistance
Zhu, Y., Hu, Y., Huang, T., Zhang, Y., Li, Z., Luo, C., Luo, Y., Yuan, H., Hisatome, I., Yamamoto, T., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.080 · Cited by 307 · see citing works
The role of low-grade inflammation in the polycystic ovary syndrome
Repaci, A., Gambineri, A., & Pasquali, R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 300 · see citing works
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294 · see citing works
Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation
Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 297 · see citing works
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Gnanadass, S. A., Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 299 · see citing works
Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review
Mohammadi, M. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_576_17 · Cited by 265 · see citing works
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 267 · see citing works
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Diamanti‐Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N. L., Kreatsas, G., & Panidis, D. (2006) · Human Reproduction · doi:10.1093/humrep/del003 · Cited by 258 · see citing works
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
Orio, F., Palomba, S., Cascella, T., Biase, S. D., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 257 · see citing works
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
Harborne, L., Fleming, R., Lyall, H., Norman, J. E., & Sattar, N. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13493-9 · Cited by 256 · see citing works
First-Trimester C-Reactive Protein and Subsequent Gestational Diabetes
Wolf, M. S., Sandler, L., Hsu, K., Smirnakis, K. V., Ecker, J. L., & Thadhani, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.819 · Cited by 251 · see citing works
Inflammation and Human Ovarian Follicular Dynamics
Boots, C. E., & Jungheim, E. S. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554928 · Cited by 252 · see citing works
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
Morin-Papunen, L. C., Rautio, K., Ruokonen, A., Hedberg, P. S. M., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 245 · see citing works
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 229 · see citing works
Increased Activation of Nuclear Factor κB Triggers Inflammation and Insulin Resistance in Polycystic Ovary Syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2327 · Cited by 228 · see citing works
Central Fat Excess in Polycystic Ovary Syndrome: Relation to Low-Grade Inflammation and Insulin Resistance
Puder, J. J., Varga, S., Kraenzlin, M., Geyter, C. D., Keller, U. B., & Müller-Stich, B. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1002 · Cited by 216 · see citing works
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
Savant, S. S., Sriramkumar, S., & O’Hagan, H. M. (2018) · Cancers · doi:10.3390/cancers10080251 · Cited by 211 · see citing works
Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort
Nohr, E. A., Bech, B. H., Væth, M., Rasmussen, K. M., Henriksen, T. B., & Olsen, J. (2007) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2007.00762.x · Cited by 204 · see citing works
Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity
Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & Millán, J. L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 199 · see citing works
Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis
Juran, R., Kerchner, A., Maifeld, M., van Beek, E. J. R., Jagasia, D. H., & Dokras, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1343 · Cited by 194 · see citing works
Polycystic Ovary Syndrome
Nandi, A. A., Chen, Z., Patel, R., & Poretsky, L. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.003 · Cited by 187 · see citing works
The polycystic ovary syndrome per se is not associated with increased chronic inflammation
Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlößer, H. W., Brabant, G. E., & Schöfl, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500525 · Cited by 182 · see citing works
The epithelial barrier theory and its associated diseases
Sun, N., Öğülür, İ., Mitamura, Y., Yazıcı, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardıçlı, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 188 · see citing works
Inflammation and Glucose Intolerance
Wolf, M. S., Sauk, J. S., Shah, A., Smirnakis, K. V., Jimenez-Kimble, R., Ecker, J. L., & Thadhani, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.21 · Cited by 175 · see citing works
Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids
Ye, Z., Wang, S., Zhang, C., & Zhao, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00617 · Cited by 173 · see citing works
Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity
Ibáñez, L., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031281 · Cited by 172 · see citing works
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome
Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2363 · Cited by 171 · see citing works
Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome
Ostadmohammadi, V., Jamilian, M., Bahmani, F., & Asemi, Z. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0480-x · Cited by 174 · see citing works
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
Diamanti‐Kandarakis, E., Baillargeon, J., Iuorno, M. J., Jakubowicz, D. J., & Nestler, J. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021528 · Cited by 170 · see citing works
Recurrent pregnancy loss: A disease of inflammation and coagulation
Kwak-Kim, J. Y.-H., Yang, K. M., & Gilman‐Sachs, A. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01079.x · Cited by 168 · see citing works
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168 · see citing works
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.007 · Cited by 167 · see citing works
Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome
Luque‐Ramírez, M., Mendieta-Azcona, C., Alvarez-Blasco, F., & Escobar-Morreale, H. F. (2007) · Human Reproduction · doi:10.1093/humrep/dem324 · Cited by 155 · see citing works
Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients
Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154 · see citing works
Inflammatory Markers in Women with Polycystic Ovary Syndrome
Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M., & Smolarczyk, R. (2020) · BioMed Research International · doi:10.1155/2020/4092470 · Cited by 155 · see citing works
Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients
Sun, L., Hu, W., Liu, Q., Hao, Q., Sun, B. H., Zhang, Q., Mao, S., Qiao, J., & Yan, X. (2012) · Journal of Proteome Research · doi:10.1021/pr3000317 · Cited by 153 · see citing works
Insulin Resistance, the Metabolic Syndrome, Diabetes, and Cardiovascular Disease Risk in Women with PCOS
Teede, H. J., Hutchison, S. K., Zoungas, S., & Meyer, C. (2006) · Endocrine · doi:10.1385/endo:30:1:45 · Cited by 147 · see citing works
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
Baranova, A. V., Tran, T., Birerdinc, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04579.x · Cited by 146 · see citing works
Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women
Escobar-Morreale, H. F., Villuendas, G., Botella-Carretero, J. I., Sancho, J., & Millán, J. L. S. (2003) · Diabetologia · doi:10.1007/s00125-003-1090-z · Cited by 143 · see citing works
Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial
Banaszewska, B., Pawelczyk, L., Spaczynski, R. Z., Dziura, J., & Duleba, A. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1988 · Cited by 143 · see citing works
Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index
Samy, N., Hashim, M., Sayed, M., & Said, M. (2009) · Disease Markers · doi:10.1155/2009/465203 · Cited by 142 · see citing works
The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study
Sathyapalan, T., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1750 · Cited by 140 · see citing works
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
Su, P., Chen, C., & Sun, Y. W. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01621-6 · Cited by 135 · see citing works
Induction of Oxidative Stress and Human Leukocyte/Endothelial Cell Interactions in Polycystic Ovary Syndrome Patients with Insulin Resistance
Víctor, V. M., Rocha, M., Bañuls, C., Álvarez, Á., de Pablo, C., Sánchez-Serrano, M., Gomez, M., & Hernández‐Mijares, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0651 · Cited by 132 · see citing works
Markers of insulin resistance in Polycystic ovary syndrome women: An update
Amisi, C. A. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.129 · Cited by 149 · see citing works
Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128 · see citing works
Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages†
Lima, P., Nivet, A., Wang, Q., Chen, Y.-A., Leader, A., Cheung, A., Tzeng, C., & Tsang, B. K. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy096 · Cited by 124 · see citing works
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome
Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0399 · Cited by 120 · see citing works
Inflammation and reproductive function in women with polycystic ovary syndrome†
Velez, L. M., Seldin, M., & Motta, A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab050 · Cited by 106 · see citing works
Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117 · see citing works
The importance of insulin resistance in polycystic ovary syndrome
Goodarzi, M. O., & Korenman, S. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00734-9 · Cited by 118 · see citing works
Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance
Víctor, V. M., Rocha, M., Bañuls, C., Sánchez-Serrano, M., Solá, E., Gomez, M., & Hernández‐Mijares, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0466 · Cited by 116 · see citing works
Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114 · see citing works
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112 · see citing works
Association Between Polycystic Ovary Syndrome and Cancer Risk
Yin, W., Falconer, H., Yin, L., Xu, L., & Ye, W. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5188 · Cited by 112 · see citing works
The −597 G→A and −174 G→C Polymorphisms in the Promoter of the IL-6 Gene Are Associated with Hyperandrogenism
Villuendas, G., Millán, J. L. S., Sancho, J., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8309 · Cited by 112 · see citing works
Metabolic Cardiovascular Disease Risk Factors in Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
Taponen, S., Martikainen, H. K., Järvelin, M., Sovio, U., Laitinen, J. H., Pouta, A. M., Hartikainen, A., McCarthy, M. I., Franks, S., Paldanius, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031720 · Cited by 111 · see citing works
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Bickerton, A. S. T., Clark, N. M., Meeking, D. R., Shaw, K. M., Crook, M. A., Lumb, P. J., Turner, C., & Cummings, M. H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015271 · Cited by 109 · see citing works
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
Ibáñez, L., & de Zegher, F. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi054 · Cited by 109 · see citing works
Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108 · see citing works
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment
Banaszewska, B., Pawelczyk, L. A., Spaczyński, R., & Dulęba, A. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0501 · Cited by 107 · see citing works
Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome
González, F., Sia, C. L., Shepard, M. K., Rote, N. S., & Minium, J. (2012) · Human Reproduction · doi:10.1093/humrep/des320 · Cited by 106 · see citing works
Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome
Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 106 · see citing works
Heart Rate Variability in Young Women with Polycystic Ovary Syndrome
Yı́ldı́rı́r, A., Aybar, F., Kabakçı, G., Yaralı́, H., & Oto, A. (2006) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2006.00122.x · Cited by 105 · see citing works
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 104 · see citing works
American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome
Cobin, R. H., Futterweit, W., Nestler, J. E., Reaven, G. M., Jellinger, P. S., Handelsman, Y., Redmond, G. P., & Thatcher, S. S. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.125 · Cited by 104 · see citing works
The latest reports and treatment methods on polycystic ovary syndrome
Stańczak, N. A., Grywalska, E., & Dudzińska, E. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2357737 · Cited by 147 · see citing works
The Role of Obesity in the Development of Polycystic Ovary Syndrome
Motta, A. B. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092482 · Cited by 103 · see citing works
Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Peng, Z., Sun, Y., Lv, X., Zhang, H., Liu, C., & Dai, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148531 · Cited by 102 · see citing works
The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes
Çakıroğlu, Y., Vural, F., & Vural, B. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0446-4 · Cited by 101 · see citing works
The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 98 · see citing works
The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism
Peral, B., Millán, J. L. S., Castello, R., Moghetti, P., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8715 · Cited by 99 · see citing works
Altered Trace Mineral Milieu Might Play An Aetiological Role in the Pathogenesis of Polycystic Ovary Syndrome
Chakraborty, P., Ghosh, S., Goswami, S. K., Kabir, S. N., Chakravarty, B., & Jana, K. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9592-5 · Cited by 98 · see citing works
Association of Polymorphisms in the Interleukin 6 Receptor Complex with Obesity and Hyperandrogenism
Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & Millán, J. L. S. (2003) · Obesity Research · doi:10.1038/oby.2003.136 · Cited by 97 · see citing works
Hyperglycemia Alters Tumor Necrosis Factor-α Release from Mononuclear Cells in Women with Polycystic Ovary Syndrome
González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0694 · Cited by 97 · see citing works
Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
Alves, A. C., Valcarcel, B., Mäkinen, V.-P., Morin-Papunen, L. C., Sebert, S. P., Kangas, A. J., Soininen, P., Das, S., Iorio, M. D., Coin, L., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.126 · Cited by 96 · see citing works
High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception
Ibáñez, L., Jaramillo, A. M. A., Ferrer, A., & de Zegher, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei072 · Cited by 94 · see citing works
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener‐Victorin, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2279 · Cited by 93 · see citing works
Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?
Popovic, M., Sartorius, G. A., & Christ‐Crain, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00737-4 · Cited by 92 · see citing works
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 94 · see citing works
The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case–control study
Kurt, R. K., Okyay, A. G., Hakverdi, A. U., Güngören, A., Dolapçıoğlu, K., Karateke, A., & Dogan, M. O. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3199-3 · Cited by 91 · see citing works
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Nicoli, A., Amarri, S., Sala, G. B. L., & Street, M. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00879 · Cited by 90 · see citing works
Menstrual irregularity and asthma and lung function
Real, F. G., Svanes, C., Omenaas, E. R., Antó, J. M., Plana, E., Janson, C., Jarvis, D., Zemp, E., Wjst, M., Leynaert, B., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.041 · Cited by 90 · see citing works

The changes of C-reactive protein in polycystic ovarian syndrome and its significance
Gui, F. (2008) · Zhongguo fuyou baojian
Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary Syndrome
Ruan, X., & Dai, Y. (2009) · Medical Principles and Practice · doi:10.1159/000189809 · Cited by 34 · see citing works
Serum C-reactive protein and its relationship with clinic factors in patients with polycystic ovary syndrome
Wang, L. (2007) · Chinese Journal of Clinical Obstetrics and Gynecology
Chronic Inflammation in Women with Polycystic Ovarian Syndrome
Üstüner, İ., Sönmezer, M., Atabekoğlu, C. S., Ergün, A., Güllü, S., & Aytaç, R. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3 · see citing works
The polycystic ovary syndrome per se is not associated with increased chronic inflammation
Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlößer, H. W., Brabant, G. E., & Schöfl, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500525 · Cited by 182 · see citing works

Authors: Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N.
Affiliations: University of Glasgow (GB)
Corresponding author: Sattar, Naveed
ORCID: Petrie, John R.
Gould, Gwyn W.
Sattar, Naveed
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2001-06
Volume: 86
Issue: 6
Pages: 2453-2455
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.86.6.7580
OpenAlex: W2168847507
Cited by: 640
References: 26
Citations by year: 2026: 22 · 2025: 26 · 2024: 21 · 2023: 32 · 2022: 25 · 2021: 41 · 2020: 28 · 2019: 22 · 2018: 20 · 2017: 19 · 2016: 20 · 2015: 19 · 2014: 28 · 2013: 21 · 2012: 35
FWCI: 18.68
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, low-grade inflammation, C-reactive protein, insulin resistance, coronary heart disease risk, type 2 diabetes risk, body mass index, hyperinsulinemic-euglycemic clamp, testosterone, women
MeSH terms: Adult, C-Reactive Protein, Chronic Disease, Female, Humans, Inflammation, Insulin Resistance, Osmolar Concentration, Polycystic Ovary Syndrome, Reference Values, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Low grade chronic inflammation in women with polycystic ovarian syndrome

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks